Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment.

Strand V, Sharp V, Koenig AS, Park G, Shi Y, Wang B, Zack DJ, Fiorentino D.

Ann Rheum Dis. 2012 Jul;71(7):1143-50. doi: 10.1136/annrheumdis-2011-200387. Epub 2012 Jan 17.

2.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

3.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review.

Woolacott NF, Khadjesari ZC, Bruce IN, Riemsma RP.

Clin Exp Rheumatol. 2006 Sep-Oct;24(5):587-93. Review.

PMID:
17181932
4.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

5.
6.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Tobin AM, Kirby B.

BioDrugs. 2005;19(1):47-57. Review.

PMID:
15691217
7.

Effectiveness of psoriatic arthritis therapies.

Gladman DD.

Semin Arthritis Rheum. 2003 Aug;33(1):29-37. Review.

PMID:
12920694
8.

The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis.

Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, Scott DL, Steer S.

Semin Arthritis Rheum. 2014 Oct;44(2):123-30. doi: 10.1016/j.semarthrit.2014.05.001. Epub 2014 May 29. Review.

9.
10.

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis.

Galadari H, Fuchs B, Lebwohl M.

Int J Dermatol. 2003 Mar;42(3):231-7. Review.

PMID:
12653923
11.

Etanercept: an evolving role in psoriasis and psoriatic arthritis.

Prodanovich S, Ricotti C, Glick BP, Inverardi L, Leonardi CL, Kerdel F.

Am J Clin Dermatol. 2010;11 Suppl 1:3-9. doi: 10.2165/1153413-S0-000000000-00000. Review.

PMID:
20586498
12.
13.

Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.

Farahani P, Levine M, Gaebel K, Thabane L.

Can J Clin Pharmacol. 2005 Fall;12(3):e254-63. Epub 2005 Nov 7. Review.

14.

Safety of anti-TNF╬▒ agents in the treatment of psoriasis and psoriatic arthritis.

Girolomoni G, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Peserico A, Puglisi Guerra A, Vena GA.

Immunopharmacol Immunotoxicol. 2012 Aug;34(4):548-60. doi: 10.3109/08923973.2011.653646. Epub 2012 Feb 2. Review.

PMID:
22296031
15.

Etanercept and efalizumab for the treatment of psoriasis: a systematic review.

Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. Review.

16.

Etanercept: a review of its use in the management of rheumatoid arthritis.

Dhillon S, Lyseng-Williamson KA, Scott LJ.

Drugs. 2007;67(8):1211-41. Review. Erratum in: Drugs. 2007;67(13):1849.

PMID:
17521223
17.

Etanercept (Enbrel): update on therapeutic use.

Spencer-Green G.

Ann Rheum Dis. 2000 Nov;59 Suppl 1:i46-9. Review.

18.

Etanercept in psoriatic arthritis.

Anandarajah AP, Ritchlin CT.

Expert Opin Biol Ther. 2003 Feb;3(1):169-77. Review.

PMID:
12718739
19.

Etanercept (Enbrel) -- an update.

Goffe B.

Skin Therapy Lett. 2004 Dec-2005 Jan;9(10):1-4, 9. Review.

20.

Use of etanercept in the treatment of psoriasis and psoriatic arthritis.

Fuchs BS, Hadi S.

Rev Recent Clin Trials. 2006 Sep;1(3):259-63. Review.

PMID:
18473978
Items per page

Supplemental Content

Write to the Help Desk